Comprehensive Guide to Metabotropic and Enzyme-Linked Receptors

Classification of Receptors Based on Location and Solubility

Cell Surface Receptors * Ligand Properties: Ligands that bind to cell surface receptors are typically hydrophilic (water-soluble) and lipophobic (fat-insoluble). * Membrane Interactions: Because the cell membrane is composed of a phospholipid bilayer, hydrophilic proteins cannot pass through the lipid interior. Consequently, they require a receptor on the cell's surface to trigger activity inside the cell. * Types of Cell Surface Receptors: * Enzyme-linked receptors. * Metabotropic receptors. * Ionotropic receptors.
Intracellular Receptors * Location: Found inside the cell, often targeting the nucleus. * Ligand Properties: Ligands are lipophilic (fat-soluble), allowing them to dissolve in the fat of the phospholipid bilayer and pass directly through the cell membrane. * Mechanism of Action: Once inside, they cause protein synthesis and gene transcription.

G Protein-Coupled Receptors (GPCRs)

Definition: GPCRs are also known as metabotropic receptors.
G Protein Nomenclature: The "G" stands for guanine nucleotide binding protein.
Prevalence and Significance: * GPCRs are the most common receptors in the body. * Approximately $4\%$ of the human genome (roughly $800$ genes) encodes for these receptors. * They are involved in a vast array of physiological processes, including heart rate regulation (increase and decrease), bronchoconstriction, bronchodilation, and light detection in the retina (rhodopsin). * Approximately $40\%$ of all modern medicinal drugs target GPCRs.
General Structure: * GPCRs consist of a single polypeptide chain. * They possess seven transmembrane helixes ( $7$ segments that pass through the membrane). * Binding Domains: Ligands can bind to either the extracellular domain or within the transmembrane domain helixes.
The G Protein Subunits: * The G protein itself is heterotrimeric, consisting of three subunits: $\alpha$ (alpha), $\beta$ (beta), and $\gamma$ (gamma). * The $\alpha$ subunit is the primary focus for intracellular signaling and is categorized into three main types: * $G_S$ : Stimulatory; activates adenylate cyclase. * $G_I$ : Inhibitory; inhibits adenylate cyclase. * $G_Q$ : Activates phospholipase C ( $PLC$ ).

G Protein Recycling and Activation Model

Inactive State: In its resting state, the $\alpha$ subunit of the G protein is bound to guanosine diphosphate ( $GDP$ ).
Activation Process: 1. A ligand binds to the extracellular side of the GPCR, causing a conformational (shape) change in the receptor. 2. This change triggers the displacement of $GDP$ from the $\alpha$ subunit, replacing it with guanosine triphosphate ( $GTP$ ). 3. The binding of $GTP$ activates the G protein, causing the $\alpha$ subunit to dissociate (split) from the $\beta$ and $\gamma$ subunits. 4. The activated $\alpha$ - $GTP$ complex moves to bind with an effector enzyme to initiate signaling.
Signal Conclusion (Hydrolysis): 1. The $\alpha$ subunit eventually hydrolyzes the bound $GTP$ back into $GDP$ . 2. Once converted back to $GDP$ , the $\alpha$ subunit becomes inactive and reassociates with the $\beta$ and $\gamma$ subunits and the receptor, completing the cycle.

Second Messenger Systems and Effectors

Adenylate Cyclase Pathway: * $G_S$ Stimulus: Increases cyclic adenosine monophosphate ( $cAMP$ ). * $G_I$ Stimulus: Decreases $cAMP$ . * Clinical Impact: $cAMP$ activates protein kinase A ( $PKA$ ), leading to effects such as bronchodilation.
Phospholipase C (PLC) Pathway: * $G_Q$ Activation: Activates $PLC$ , which cleaves membrane phospholipids into two second messengers: 1. Inositol triphosphate ( $IP_3$ ): Triggers the release of calcium ( $Ca^{2+}$ ) from the endoplasmic reticulum, leading to cellular responses like muscle contraction. 2. Diacylglycerol ( $DAG$ ): Activates protein kinase C ( $PKC$ ).
Ion Channel Coupling: * GPCRs can indirectly open or close ion channels via G proteins. * Example: Muscarinic acetylcholine receptors ( $M$ receptors) in the heart and sweat glands. Unlike nicotinic receptors (which are ligand-gated ion channels), muscarinic receptors must signal through a G protein to affect ion channels, leading to depolarization or hyperpolarization.

Structure-Activity Relationship (SAR): Asthma and Adrenergic Receptors

Asthma Pathophysiology: A syndrome where allergic stimuli (e.g., pollen, dust) trigger bronchospasm—a life-threatening narrowing of the bronchioles.
Adrenergic Receptor Targets: * $\alpha$ Receptors: Cause vasoconstriction and bronchoconstriction. * $\beta_1$ Receptors: Increase heart rate. * $\beta_2$ Receptors: Cause bronchodilation.
The SAR of Noradrenaline (Norepinephrine): * Structure: Contains a benzene ring with hydroxyl ( $OH$ ) groups. Hydroxyl groups increase hydrogen bonding, which increases receptor affinity (binding strength). * Limitation: Noradrenaline is highly potent but non-selective; it binds to both $\alpha$ and $\beta$ receptors. In a disease state like asthma, non-selective activation of $\alpha$ receptors can worsen constriction.
Pharmacological Modification (Tweaking): * Goal: Create a selective $\beta_2$ agonist to induce bronchodilation without $\alpha$ or $\beta_1$ effects. * Mechanism: Adrenergic receptors have different binding pocket sizes. While noradrenaline is small and fits into many receptors, pharmacologists add "bulky groups" to the molecule. * Evolution of Selectivity: * Noradrenaline: Small; fits $\alpha$ and $\beta$ receptors. * Isoprotolase (Isoprenaline): Addition of a larger group makes it selective for $\beta$ receptors (both $\beta_1$ and $\beta_2$ ) because it becomes too large to fit into the $\alpha$ receptor pocket. * Salbutamol: Further structural modifications (adding specific groups) make it a selective $\beta_2$ agonist. It does not activate $\alpha$ or $\beta_1$ significantly, making it ideal for treating bronchospasm in asthma.

Enzyme-Linked Receptors: Receptor Tyrosine Kinases (RTK)

Primary Example: The insulin receptor.
Structure: * RTKs are cell surface receptors. * $\alpha$ Subunit: Located extracellularly; serves as the binding domain for the ligand (e.g., insulin). * $\beta$ Subunit: Located intracellularly; linked to the kinase enzyme.
Mechanism of Activation: 1. Ligand Binding: A hydrophilic/lipophobic ligand (like the peptide insulin) binds to the $\alpha$ subunit. 2. Receptor Dimerization: Two individual receptor units come together to form a pair, or "dimer." 3. Auto-phosphorylation: As they dimerize, they activate the kinase on the $\beta$ subunit, which performs auto-phosphorylation on tyrosine residues. 4. Signal Cascade: These phosphorylated sites act as docking points for other intracellular proteins, initiating a cascade. 5. Cellular Response: In the case of insulin, this cascade triggers the exocytosis of $GLUT4$ (glucose transporter) to the cell membrane, allowing the cell to take up glucose.

Questions & Discussion

Q: Which of the following best describes a metabotropic receptor? * A: A cell surface receptor that works via an intracellular signaling pathway.
Q: Describe the structure of a GPCR. * A: A single polypeptide with seven transmembrane helixes.
Q: A drug activates a $G_Q$ coupled receptor on smooth muscle. Which second messenger pathway is activated? * A: Phospholipase C ( $PLC$ ).
Q: How is a G protein switched off after activation? * A: Lowering of activity via the hydrolysis of $GTP$ back to $GDP$ by the $\alpha$ subunit.
Q: Which modification produces a $\beta_2$ selective agonist for asthma? * A: Adding a large, bulky group to the nitrogen of the molecule (e.g., Salbutamol).
Q: Describe the activation of Receptor Tyrosine Kinases (RTK). * A: Ligand binding leads to receptor dimerization, activation of the intracellular kinase domain, and auto-phosphorylation of tyrosine residues.
Q: Which enzyme is activated by the $G_S$ pathway to convert $ATP$ into a second messenger? * A: Adenylate cyclase.
Q: What is the second messenger produced by adenylate cyclase that activates protein kinase A ( $PKA$ )? * A: cyclic adenosine monophosphate ( $cAMP$ ).
Q: Which G alpha subtype inhibits adenylate cyclase? * A: $G_I$ .
Q: Which enzyme downstream of $G_Q$ cleaves phospholipids into $IP_3$ and $DAG$ ? * A: Phospholipase C ( $PLC$ ).
Q: Which specific GPCR on bronchial smooth muscle do noradrenaline and salbutamol bind to for bronchodilation? * A: The $\beta_2$ adrenergic receptor.